Suchergebnisse
Zoetis Q2 Earnings Beat Estimates, Revenues Miss, 2026 View Cut
Zoetis, Inc. ZTS delivered second-quarter 2026 adjusted earnings (excluding one-time items) of $1.87 per share, which beat the Zacks Consensus Estimate of $1.84. In the year-ago quarter, the company
Fiserv Q2 Earnings Call Highlights
Key Points
- Interested in Fiserv, Inc.? Here are five stocks we like better.
- Fiserv lowered its full-year outlook, now expecting organic revenue growth of negative 1% to flat, adjusted revenue to
Dole's Q2 Earnings Upcoming: Here's What Lies Ahead for the Stock
Dole plc DOLE is slated to report second-quarter 2026 results on Aug. 10, before market open. The company is likely to report a top-line increase when it posts the quarterly results.For revenues
HUBS Q2 Earnings Call Highlights AI Pivot and Budget Pressure
HubSpot, Inc. HUBS used its earnings call for the second quarter of 2026 to frame weaker customer acquisition and a softer near-term outlook as the result of an intentional AI transition and greater
Is Shell Stock a Buy as Cash Flow Surges but Risks Stay Elevated?
Shell plc SHEL delivered a sharp second-quarter recovery, with stronger earnings, substantial cash generation and a lower debt load. Its discounted valuation and continued shareholder distributions
Realty Income Q2 Earnings Call Raises 2026 Growth Targets
Realty Income Corporation O raised full-year AFFO and investment targets on its second-quarter 2026 earnings call, citing a broader pipeline and improved funding visibility.
President and CEO Sumit
Should Investors Hold on to Astera Labs Stock Post Q2 Earnings?
Astera Labs ALAB shares have lost 12% since it reported second-quarter 2026 results on Aug. 4, 2026. The company’s second-quarter earnings suffered from higher operating expenses due to continued
How Jacobs' AI Infrastructure Push Could Drive Its Next Growth Phase
Jacobs Solutions Inc. J is turning Artificial Intelligence infrastructure into a meaningful growth engine. Fiscal third-quarter results showed that the opportunity now extends beyond data centers
Genmab A/S Q2 Earnings Call Highlights
Key Points
- Interested in Genmab A/S Sponsored ADR? Here are five stocks we like better.
- Genmab raised its 2026 outlook, now forecasting revenue of DKK 4.3 billion–DKK 4.5 billion and operating
GoodRx Q2 Earnings Call Highlights
Key Points
- Interested in GoodRx Holdings, Inc.? Here are five stocks we like better.
- GoodRx raised its full-year outlook after reporting Q2 revenue of $200.4 million and adjusted EBITDA of $63.7
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
AngioDynamics, Inc. ANGO offers investors a clear trade-off. Its Med Tech platforms are expanding quickly, but near-term earnings conversion remains weak as tariffs and operating costs absorb part
Micron & 2 Profitable Stocks Smart Investors Are Buying in August
Historically, August has been a volatile month for the stock market, but this year it has relatively begun on a steady note. Banking on this optimism, investors should focus on companies that
Quantinuum's First Earnings After its IPO: Buy or Sell QNT Stock?
Quantinuum Inc. QNT is scheduled to release second-quarter 2026 results after the closing bell on Aug. 11. The earnings report will cover the three months ended June 30 and will mark Quantinuum’s
Thryv Launches AI Growth Platform to Help Local Businesses Capture More Leads
Key Points
- Interested in Thryv Holdings, Inc.? Here are five stocks we like better.
- Thryv launched its AI-enabled Growth Platform to help small and midsize service businesses improve online
Lightbridge Q2 Earnings Call Highlights
Key Points
- Interested in Lightbridge Corporation? Here are five stocks we like better.
- Fuel testing advanced: Lightbridge removed its first irradiated fuel samples from Idaho National
Ardelyx Q2 Earnings Call Highlights
Key Points
- Interested in Ardelyx, Inc.? Here are five stocks we like better.
- Second-quarter product revenue reached a record $118 million, up 31% year over year, but Ardelyx lowered its 2026
Cleanspark Q3 Earnings Call Highlights
Key Points
- Interested in Cleanspark, Inc.? Here are five stocks we like better.
- CleanSpark reported $138 million in fiscal Q3 revenue, up 1% sequentially, while its GAAP net loss narrowed to
Denali Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Denali Therapeutics Inc.? Here are five stocks we like better.
- AVLAYAH generated $3.6 million in its first full commercial quarter for Hunter syndrome, with payer
CVRx Q2 Earnings Call Highlights
Key Points
- Interested in CVRx, Inc.? Here are five stocks we like better.
- CVRx lowered its 2026 outlook due to sales-force turnover, slower territory-manager productivity ramps and